Stem cell activation in adults can reverse detrimental changes in body composition to reduce fat and increase lean mass in both sexes
- 25 July 2011
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 112 (12) , 3638-3647
Abstract
Detrimental changes in body composition are often associated with declining levels of testosterone. Here, we evaluated the notion that multipotent mesenchymal stem cells, that give rise to both fat and muscle tissue, can play a significant role to alter existing body composition in the adult. Transgenic mice with targeted androgen receptor (AR) overexpression in stem cells were employed. Wild‐type littermate and AR‐transgenic male and female mice were gonadectomized and left untreated for 2 months. After the hypogonadal period, mice were then treated with 5α‐dihydrotestosterone (DHT) for 6 weeks. After orchidectomy (ORX), wild‐type males have reduced lean mass and increased fat mass compared to shams. DHT treatment was beneficial to partially restore body composition. In wild‐type females, ovariectomy (OVX) produced a similar change but there was no improvement with DHT. In targeted AR transgenic mice, DHT treatment increased lean and reduced fat mass to sham levels. In contrast to wild‐type females, DHT treatment in female transgenic mice significantly ameliorated the increased fat and decreased lean mass changes that result after OVX. Our results show that DHT administration reduces fat mass and increases lean mass in wild‐type males but not females, indicating that wild‐type females are not as sensitive to androgen treatment. Because both male and female transgenic mice are more responsive than wild‐type, results suggest that body composition remains linked to stem cell fate in the adult and that targeted androgen signaling in stem cells can play a significant role to reverse detrimental changes in body composition in both sexes. J. Cell. Biochem. 112: 3638–3647, 2011.Keywords
This publication has 51 references indexed in Scilit:
- Bone vs. fat: Embryonic origin of progenitors determines response to androgen in adipocytes and osteoblastsBone, 2011
- Effects of Risedronate and Low-Dose Transdermal Testosterone on Bone Mineral Density in Women with Anorexia Nervosa: A Randomized, Placebo-Controlled StudyThe Journal of Clinical Endocrinology & Metabolism, 2011
- Intramyocardial Stem Cell Injection in Patients With Ischemic CardiomyopathyCirculation Research, 2011
- Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocationJournal of Cellular Biochemistry, 2011
- Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and DifferentiationCirculation Research, 2010
- Signaling pathways implicated in androgen regulation of endocortical boneBone, 2010
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial InfarctionJACC, 2009
- The benefits and risks of testosterone replacement therapy: a reviewTherapeutics and Clinical Risk Management, 2009
- Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytesMolecular and Cellular Endocrinology, 2008
- Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesisBone, 2008